AVH on NASDAQ, page-517

Now compare potential topline income streams you get by spending that money. If you want real growth that's how you get there. I'd just add they cut expenses by nearly 40% during a difficult time, so they are minding their business. Thanks to a well timed cap raise last year they have enough cash to get through 2020 not including increasing revenue from their current market and outpatient burns starting next year. I've done very well with this stock and still think it has a bright future. FDA approvals are a time consuming and expensive process but if you postpone them someone else will take away your opportunity at some point. If they wait to build bottom line before they grow the top line, they'll lose their chance. Please buy more PNV, it's obviously better suited to your outlook.
That said it's a good time to have your boat in a safe harbor waiting out the storm.